Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer

Update Il y a 4 ans
Reference: NCT00754351

Woman Man

  • | Country :
  • Greece
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study will evaluate the efficacy and toxicity of docetaxel, gemcitabine and bevacizumab combination, administered biweekly, as salvage treatment in patients with metastatic and HER2 negative breast cancer.


Inclusion criteria

  • Breast Cancer

Links